Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HSP70 Heat-Shock Proteins | 6 | 2023 | 397 | 1.620 |
Why?
|
Facial Transplantation | 5 | 2023 | 221 | 1.020 |
Why?
|
Molecular Chaperones | 6 | 2024 | 754 | 0.890 |
Why?
|
Graft Rejection | 12 | 2023 | 4446 | 0.880 |
Why?
|
Dendritic Cells | 6 | 2018 | 2722 | 0.760 |
Why?
|
Immunity, Humoral | 3 | 2022 | 600 | 0.690 |
Why?
|
Skin Transplantation | 2 | 2022 | 1083 | 0.660 |
Why?
|
Immunity, Innate | 4 | 2023 | 3045 | 0.630 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 95 | 0.600 |
Why?
|
Chemokines | 1 | 2022 | 954 | 0.590 |
Why?
|
T-Lymphocytes | 7 | 2023 | 10175 | 0.560 |
Why?
|
Heat-Shock Proteins | 4 | 2024 | 795 | 0.500 |
Why?
|
Receptors, Scavenger | 3 | 2023 | 123 | 0.490 |
Why?
|
Kidney Transplantation | 6 | 2023 | 4236 | 0.480 |
Why?
|
Immunity, Cellular | 3 | 2022 | 1550 | 0.480 |
Why?
|
T-Lymphocytes, Regulatory | 9 | 2024 | 3077 | 0.450 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2013 | 26 | 0.450 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 102 | 0.430 |
Why?
|
Scavenger Receptors, Class F | 3 | 2020 | 16 | 0.420 |
Why?
|
Interleukin-2 | 4 | 2024 | 1887 | 0.410 |
Why?
|
Th1 Cells | 2 | 2018 | 1027 | 0.390 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2021 | 4366 | 0.380 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1434 | 0.380 |
Why?
|
Melanoma, Experimental | 3 | 2014 | 561 | 0.380 |
Why?
|
Interleukin-17 | 2 | 2020 | 911 | 0.370 |
Why?
|
Heart Transplantation | 2 | 2021 | 3232 | 0.370 |
Why?
|
Graft Survival | 3 | 2024 | 3820 | 0.360 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 306 | 0.330 |
Why?
|
Interferon-gamma | 3 | 2018 | 3145 | 0.320 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1894 | 0.320 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2019 | 138 | 0.310 |
Why?
|
Interleukin-10 | 5 | 2018 | 1172 | 0.300 |
Why?
|
Antigens, CD | 1 | 2018 | 3998 | 0.300 |
Why?
|
Mycoplasma hyopneumoniae | 2 | 2017 | 2 | 0.280 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2020 | 365 | 0.240 |
Why?
|
Vaccines, Synthetic | 3 | 2022 | 612 | 0.230 |
Why?
|
Mice, Inbred C57BL | 15 | 2020 | 22115 | 0.220 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 6188 | 0.210 |
Why?
|
Receptors, Purinergic P2X7 | 2 | 2013 | 85 | 0.210 |
Why?
|
Transplantation, Homologous | 5 | 2024 | 4804 | 0.210 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2022 | 373 | 0.200 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2022 | 424 | 0.200 |
Why?
|
STAT3 Transcription Factor | 2 | 2018 | 871 | 0.190 |
Why?
|
Lipopolysaccharides | 5 | 2022 | 2202 | 0.190 |
Why?
|
Purinergic P2Y Receptor Agonists | 1 | 2020 | 5 | 0.190 |
Why?
|
Receptors, Purinergic P2Y2 | 1 | 2020 | 17 | 0.180 |
Why?
|
Chemokines, CC | 1 | 2022 | 283 | 0.180 |
Why?
|
Antibodies, Viral | 5 | 2023 | 3150 | 0.180 |
Why?
|
Mice | 19 | 2024 | 81368 | 0.180 |
Why?
|
Scavenger Receptors, Class E | 1 | 2020 | 8 | 0.180 |
Why?
|
Macrophages | 4 | 2016 | 5758 | 0.170 |
Why?
|
Lectins, C-Type | 1 | 2023 | 584 | 0.170 |
Why?
|
Animals | 24 | 2024 | 168201 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2020 | 472 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 476 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4341 | 0.160 |
Why?
|
Diet, Gluten-Free | 1 | 2021 | 283 | 0.150 |
Why?
|
Immunosuppressive Agents | 4 | 2022 | 4174 | 0.150 |
Why?
|
Phagocytes | 1 | 2020 | 295 | 0.150 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 151 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2010 | 5110 | 0.150 |
Why?
|
Endocytosis | 2 | 2020 | 955 | 0.150 |
Why?
|
Dairy Products | 1 | 2021 | 490 | 0.150 |
Why?
|
Pneumonia of Swine, Mycoplasmal | 1 | 2017 | 2 | 0.140 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2018 | 168 | 0.140 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2018 | 123 | 0.140 |
Why?
|
Skin | 2 | 2022 | 4473 | 0.140 |
Why?
|
Mammals | 1 | 2023 | 1131 | 0.140 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 390 | 0.140 |
Why?
|
Antigens, Ly | 1 | 2018 | 294 | 0.140 |
Why?
|
Viral Matrix Proteins | 1 | 2018 | 196 | 0.140 |
Why?
|
Toll-Like Receptor 2 | 2 | 2013 | 345 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 2 | 2015 | 578 | 0.130 |
Why?
|
Microglia | 2 | 2022 | 1357 | 0.130 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 496 | 0.130 |
Why?
|
Granzymes | 1 | 2017 | 277 | 0.130 |
Why?
|
Mycoplasma | 1 | 2016 | 147 | 0.130 |
Why?
|
Organ Transplantation | 2 | 2024 | 1157 | 0.130 |
Why?
|
Membrane Proteins | 3 | 2018 | 7847 | 0.130 |
Why?
|
Critical Illness | 3 | 2013 | 2709 | 0.130 |
Why?
|
Medicine | 1 | 2024 | 942 | 0.130 |
Why?
|
Bacterial Proteins | 4 | 2017 | 3842 | 0.130 |
Why?
|
Mycobacterium tuberculosis | 3 | 2016 | 1914 | 0.120 |
Why?
|
Macrophage Activation | 2 | 2016 | 552 | 0.120 |
Why?
|
Cross-Priming | 1 | 2015 | 76 | 0.120 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1936 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 767 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8542 | 0.120 |
Why?
|
Toll-Like Receptor 3 | 1 | 2014 | 97 | 0.120 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1779 | 0.110 |
Why?
|
Membrane Microdomains | 1 | 2015 | 206 | 0.110 |
Why?
|
Kidney Function Tests | 1 | 2016 | 678 | 0.110 |
Why?
|
Cytokines | 7 | 2021 | 7373 | 0.110 |
Why?
|
RNA, Double-Stranded | 1 | 2014 | 294 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2838 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1085 | 0.110 |
Why?
|
Survival Analysis | 3 | 2021 | 10073 | 0.100 |
Why?
|
Viral Vaccines | 1 | 2018 | 595 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1185 | 0.100 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 292 | 0.100 |
Why?
|
Cell Movement | 4 | 2022 | 5200 | 0.100 |
Why?
|
Dermatitis, Contact | 1 | 2013 | 133 | 0.100 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
Cells, Cultured | 5 | 2019 | 18937 | 0.100 |
Why?
|
Antigen Presentation | 2 | 2015 | 1250 | 0.100 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1022 | 0.100 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2178 | 0.100 |
Why?
|
Ovalbumin | 1 | 2013 | 675 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1798 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5812 | 0.090 |
Why?
|
Humans | 31 | 2024 | 760617 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1653 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1835 | 0.080 |
Why?
|
Multiple Organ Failure | 1 | 2011 | 387 | 0.080 |
Why?
|
Synovial Fluid | 1 | 2010 | 393 | 0.080 |
Why?
|
Apoptosis | 4 | 2017 | 9476 | 0.080 |
Why?
|
Adoptive Transfer | 1 | 2010 | 818 | 0.070 |
Why?
|
Antibody Formation | 2 | 2023 | 1390 | 0.070 |
Why?
|
Phagocytosis | 3 | 2021 | 1526 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2018 | 2985 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2022 | 16967 | 0.070 |
Why?
|
Transgenes | 1 | 2010 | 1008 | 0.070 |
Why?
|
Protein Engineering | 1 | 2010 | 548 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2010 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18221 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3805 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1483 | 0.070 |
Why?
|
Down-Regulation | 1 | 2013 | 2915 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2409 | 0.060 |
Why?
|
Monocytes | 1 | 2014 | 2565 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9529 | 0.060 |
Why?
|
Female | 17 | 2022 | 392148 | 0.060 |
Why?
|
NF-kappa B | 3 | 2022 | 2481 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4020 | 0.060 |
Why?
|
Caspase 3 | 2 | 2017 | 731 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2020 | 10432 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1892 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2021 | 12758 | 0.050 |
Why?
|
Signal Transduction | 7 | 2021 | 23416 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6340 | 0.050 |
Why?
|
Untranslated Regions | 1 | 2022 | 29 | 0.050 |
Why?
|
Heat-Shock Response | 1 | 2024 | 179 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2022 | 63 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9438 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3730 | 0.050 |
Why?
|
Viral Structural Proteins | 1 | 2021 | 95 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2022 | 4571 | 0.050 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 123 | 0.050 |
Why?
|
Biology | 1 | 2024 | 290 | 0.050 |
Why?
|
Male | 15 | 2022 | 360358 | 0.050 |
Why?
|
Middle Aged | 10 | 2022 | 220584 | 0.050 |
Why?
|
Uridine Triphosphate | 1 | 2020 | 28 | 0.050 |
Why?
|
Chronic Disease | 2 | 2018 | 9311 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2022 | 522 | 0.050 |
Why?
|
Immune Tolerance | 2 | 2020 | 2299 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2022 | 3113 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4242 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2022 | 487 | 0.040 |
Why?
|
Neutrophils | 1 | 2013 | 3763 | 0.040 |
Why?
|
Tuberculosis | 1 | 2013 | 2015 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2015 | 1242 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5463 | 0.040 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1884 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29600 | 0.040 |
Why?
|
Germinal Center | 1 | 2022 | 380 | 0.040 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 243 | 0.040 |
Why?
|
Pilot Projects | 2 | 2023 | 8618 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2019 | 265 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39063 | 0.040 |
Why?
|
Adult | 8 | 2022 | 220969 | 0.040 |
Why?
|
Retinal Dehydrogenase | 1 | 2018 | 78 | 0.040 |
Why?
|
Isoantibodies | 1 | 2022 | 671 | 0.040 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2020 | 284 | 0.040 |
Why?
|
Vaccines, Subunit | 1 | 2018 | 158 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1228 | 0.040 |
Why?
|
Vero Cells | 1 | 2018 | 481 | 0.040 |
Why?
|
Histocytochemistry | 1 | 2018 | 696 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2011 | 5293 | 0.030 |
Why?
|
Sepsis | 1 | 2011 | 2585 | 0.030 |
Why?
|
Genotype | 3 | 2013 | 12978 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2022 | 974 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2013 | 15908 | 0.030 |
Why?
|
Serpins | 1 | 2017 | 247 | 0.030 |
Why?
|
Interleukins | 1 | 2020 | 783 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2022 | 1355 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4269 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 823 | 0.030 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2014 | 44 | 0.030 |
Why?
|
Poly I-C | 1 | 2014 | 112 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 793 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2016 | 14389 | 0.030 |
Why?
|
Arginase | 1 | 2014 | 78 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2414 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2022 | 3593 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 1988 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4110 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2020 | 3088 | 0.030 |
Why?
|
Bacterial Vaccines | 1 | 2016 | 399 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1668 | 0.030 |
Why?
|
Croton Oil | 1 | 2013 | 3 | 0.030 |
Why?
|
Isoenzymes | 1 | 2018 | 1687 | 0.030 |
Why?
|
Purinergic P2X Receptor Antagonists | 1 | 2013 | 24 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2135 | 0.030 |
Why?
|
Clodronic Acid | 1 | 2013 | 59 | 0.030 |
Why?
|
Virulence Factors | 1 | 2017 | 513 | 0.030 |
Why?
|
Gene Frequency | 2 | 2011 | 3601 | 0.030 |
Why?
|
Th2 Cells | 1 | 2018 | 1056 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1865 | 0.030 |
Why?
|
Lectins | 1 | 2014 | 489 | 0.030 |
Why?
|
Intestines | 1 | 2021 | 1909 | 0.020 |
Why?
|
Phenotype | 3 | 2016 | 16571 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7568 | 0.020 |
Why?
|
Species Specificity | 1 | 2016 | 2411 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3575 | 0.020 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1018 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1350 | 0.020 |
Why?
|
Alleles | 1 | 2013 | 6861 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2546 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2700 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2015 | 575 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2192 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59179 | 0.020 |
Why?
|
Cell Line | 2 | 2017 | 15576 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2013 | 778 | 0.020 |
Why?
|
Tissue Donors | 1 | 2020 | 2331 | 0.020 |
Why?
|
Aged | 5 | 2022 | 169042 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5239 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2016 | 1463 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 64568 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3370 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8311 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4117 | 0.020 |
Why?
|
Child | 3 | 2022 | 80079 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58894 | 0.020 |
Why?
|
Protein Transport | 1 | 2014 | 1966 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 74115 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3087 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3839 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42188 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1963 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2446 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 2011 | 870 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7237 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4910 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4570 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1650 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2291 | 0.020 |
Why?
|
Lung | 2 | 2018 | 9998 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2013 | 998 | 0.020 |
Why?
|
Tetrazoles | 1 | 2013 | 909 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54360 | 0.020 |
Why?
|
Swine | 1 | 2017 | 5907 | 0.020 |
Why?
|
Time Factors | 2 | 2021 | 39913 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6762 | 0.020 |
Why?
|
Pneumonia | 1 | 2018 | 2143 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6520 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1454 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5863 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4308 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1776 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88234 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9417 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9345 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5672 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15828 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11874 | 0.010 |
Why?
|
Pyridines | 1 | 2013 | 2874 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20074 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36152 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4354 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9461 | 0.010 |
Why?
|
Inflammation | 1 | 2016 | 10760 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2009 | 3742 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15251 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18381 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11514 | 0.010 |
Why?
|
Aging | 1 | 2011 | 8699 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 80566 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41457 | 0.000 |
Why?
|